Clinical trial
Mycophenolate Mofetil Versus Cyclophosphamide in the Induction Treatment of ANCA Associated Vasculitis
NCT00301652 is registered in ClinicalTrials.gov with Nanjing University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mycophenolate Mofetil Versus Cyclophosphamide in the Induction Treatment of ANCA Associated Vasculitis
- Lead sponsor
- Nanjing University School of Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2003
- Completion date
- December 31, 2005
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anti-neutrophil cytoplasmic antibody, vasculitis